rabeprazole has been researched along with mosapride in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, BH; Patel, JR; Patel, MM; Suhagia, BN | 1 |
| Arai, K; Imawari, M; Takeuchi, Y; Tsukurimichi, A; Uchida, N; Watanabe, H | 1 |
| Assefi, AR; Bertuola, R; Czerniuk, P; de Mena, F; Di Girolamo, G; Keller, GA; Simoni, MV | 1 |
| Amemoto, K; Ashida, K; Esaki, H; Fukuchi, T; Hashimoto, T; Isowa, G; Kiyota, K; Majima, K; Morikawa, H; Murotani, M; Ohyama, Y; Oka, H; Sakaguchi, M; Takao, F; Takao, M; Yamashita, H | 1 |
| Chen, D; Mao, C; Peng, A; Pu, Y; Pu, Z; Wu, X | 1 |
2 trial(s) available for rabeprazole and mosapride
| Article | Year |
|---|---|
Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzamides; Biological Availability; Cross-Over Studies; Drug Combinations; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Morpholines; Rabeprazole; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2011 |
Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzamides; Dyspepsia; Esophageal Motility Disorders; Famotidine; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Morpholines; Patient Satisfaction; Proton Pump Inhibitors; Rabeprazole | 2012 |
3 other study(ies) available for rabeprazole and mosapride
| Article | Year |
|---|---|
High-performance liquid chromatography and thin-layer chromatography for the simultaneous quantitation of rabeprazole and mosapride in pharmaceutical products.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzamides; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Morpholines; Rabeprazole; Reproducibility of Results | 2008 |
Prokinetics influence the pharmacokinetics of rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Benzamides; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydrogen-Ion Concentration; Male; Morpholines; Rabeprazole | 2008 |
Effects of mosapride combined with rabeprazole on symptom scores and inflammatory factors in elderly patients with reflux esophagitis.
Topics: Aged; Benzamides; Esophagitis, Peptic; Humans; Morpholines; Rabeprazole | 2023 |